Lumenis Unveils Next-Generation Stellar M22 with XPL Technology in Global Aesthetic Innovation

Published: 20 Nov 2025

Author: Precedence Research

Share :

Lumemis Be. Ltd. is a world leader in medical systems in the energy sector. The company launched the next iteration of its branded multi-application aesthetic platform, Stellar M22, in partnership with XPL Technology. The system is a landmark in the history of aesthetic practitioners and the first to offer unparalleled flexibility and clinical accuracy across 30+ indications. The system adds to Lumenis's long-standing reputation as the first to innovate in IPL since it was invented way back in 1993, owing to its small footprint, powerful hardware refinements, and improved workflow intelligence.

The new Stellar M22 continues the 30,000-plus installations around the globe. Designed to meet the demands of the current boom aesthetic world that places high expectations on faster, safer, and more personalized treatment. Lumenis has also taken into account input from aesthetic doctors, dermatologists, and medical spas around the world to rethink what the platform can do with the next breakthrough in pulsed light technology, XPL.

Powerful technological improvements to the platform enable professionals to treat a wide range of clinical requirements, including vascular and pigmented lesions, as well as full-scale skin tone and texture restoration. The implications of these findings for dermatology practices treating different skin types year-round are important.

They affirm the platform's reputation as consistent, reliable, and capable of clinical performance. The 850+ professionally crafted protocols in the system also enable practitioners to delegate with confidence, deliver consistent treatment quality, and increase throughput without compromising quality. Furthermore, the Stellar M22 is more than a sophisticated energy-based system. This is an enterprise-altering business booster for the coming 10 years of aesthetic medicine.

CEO Statement Tzipi Ozer-Armon

“At Lumenis, innovation defines our mission, and the new Stellar M22 with XPL Technology reflects the next chapter in our commitment to advancing aesthetic medicine. This platform embodies the precision, versatility, and clinical confidence that providers need today. We are not only delivering a device; we are equipping practices with a transformative solution that helps patients achieve meaningful, visible results.”